Sermorelin is a growth-hormone-releasing hormone (GHRH) analogue used clinically to assess growth hormone secretion. It is of interest to researchers for its ability to improve bone density, reduce scaring, fight the effects of dementia, and reduce seizure activity.
Sermorelin is one of a handful of growth hormone releasing hormone (GHRH) analogues that have been developed in recent years in an effort to preserve some of positive effects of natural GHRH while avoiding desirable effects. Sermorelin (Geref) is currently used ically to assess growth hormone secretion, but the otide is of additional interest for its abilities to:
Product
• reduce scarring following heart attack,
• increase bone density,
• improve nutrition in chronic illness,
• improve renal function,
• fight the effects of dementia, and
• reduce seizure activity.

Important Notices:

This product is sold for scientific research purposes only.
Product is provided as a lyophilized (freeze-dried) powder in a sealed, sterile vial.
The quantity on the label refers to the total amount of product inside each vial.
Additional lab supplies are required for conducting research such as bacteriostatic water for reconstitution, syringes & needles to draw from the vials, and alcohol prep pads for sanitizing vial stoppers prior to needle insertion.
Vial appearance, label, seal and cap colors may vary from product photos.

Disclaimer:
This product is not intended for human or animal consumption. It is exclusively designed for research by qualified professionals. Any potential therapeutic applications should undergo rigorous exploration, validation, and further research, including clinical trials.